Suppliers / Macfarlan Smith Ltd A Johnson Matthey

Macfarlan Smith Ltd A Johnson Matthey

United Kingdom Updated 9 July 2026

The public registers hold a second record for Macfarlan Smith Ltd A Johnson Matthey. The fuller profile, with 5 active US DMFs and 20 valid CEPs, is at Macfarlan Smith. Figures on this page cover only this record.

Macfarlan Smith Ltd A Johnson Matthey is an API manufacturer based in United Kingdom. It holds one active US drug master file across a filed portfolio of 2 molecules.

1
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Buprenorphine US FDA 1
Oxycodone SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Questions about Macfarlan Smith Ltd A Johnson Matthey

Does Macfarlan Smith Ltd A Johnson Matthey hold a US DMF or a CEP?
Macfarlan Smith Ltd A Johnson Matthey holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Macfarlan Smith Ltd A Johnson Matthey make?
2 molecules are on record against Macfarlan Smith Ltd A Johnson Matthey, including Buprenorphine and Oxycodone. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Macfarlan Smith Ltd A Johnson Matthey comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability